مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

409
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

308
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PHARMACEUTICAL SUPPLY CHAIN RISKS: A SYSTEMATIC REVIEW

Pages

  1-7

Abstract

 Introduction: Supply of medicine as a strategic product in any health system is a top priority. Pharmaceutical companies, a major player of the drug supply chain, are subject to many risks. These risks disrupt the supply of medicine in many ways such as their quantity and quality and their delivery to the right place and customers and at the right time. Therefore risk identification in the supply process of pharmaceutical companies and mitigate them is highly recommended.Objective: In this study it is attempted to investigate pharmaceutical SUPPLY CHAIN RISKS with perspective of manufacturing companies.Methods: Scopus, PubMed, Web of Science bibliographic databases and Google scholar scientific search engines were searched for pharmaceutical supply chain risk management studies with 6 different groups of keywords. All results found by keywords were reviewed and none-relevant articles were excluded by outcome of interests and researcher boundaries of study within 4 steps and through a systematic method.Results: Nine articles were included in the systematic review and totally 50 main risks based on study outcome of interest extracted which classified in 7 categories. Most of reported risks were related to supply and supplier issues.Organization and strategy issues, financial, logistic, political, market and regulatory issues were in next level of importance.Conclusion: It was shown that the majority of risks in pharmaceutical supply chain were internal risks due to processes, people and functions mismanagement which could be managed by suitable mitigation strategies.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    JABERIDOOST, MONA, NIKFAR, SHEKOUFEH, ABDOLLAHIASL, AKBAR, & DINARVAND, RASSOUL. (2013). PHARMACEUTICAL SUPPLY CHAIN RISKS: A SYSTEMATIC REVIEW. DARU JOURNAL OF PHARMACEUTICAL SCIENCE, 21(9), 1-7. SID. https://sid.ir/paper/275747/en

    Vancouver: Copy

    JABERIDOOST MONA, NIKFAR SHEKOUFEH, ABDOLLAHIASL AKBAR, DINARVAND RASSOUL. PHARMACEUTICAL SUPPLY CHAIN RISKS: A SYSTEMATIC REVIEW. DARU JOURNAL OF PHARMACEUTICAL SCIENCE[Internet]. 2013;21(9):1-7. Available from: https://sid.ir/paper/275747/en

    IEEE: Copy

    MONA JABERIDOOST, SHEKOUFEH NIKFAR, AKBAR ABDOLLAHIASL, and RASSOUL DINARVAND, “PHARMACEUTICAL SUPPLY CHAIN RISKS: A SYSTEMATIC REVIEW,” DARU JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 21, no. 9, pp. 1–7, 2013, [Online]. Available: https://sid.ir/paper/275747/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button